Gallant's Groundbreaking Stem Cell Therapy Gains FDA Safety Approval for Cats with Chronic Gingivostomatitis Gallant's first ready-to-use stem cell therapy for cats, targeting refractory FCGS, earns FDA's safety milestone. A remarkable step forward in veterinary medicine!

Gallant's Groundbreaking Stem Cell Therapy Gains FDA Safety Approval for Cats with Chronic Gingivostomatitis #USA #San_Diego #Stem_Cell_Therapy #Gallant #FCGS